Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Obesity (Silver Spring, Md.)|December 19, 2014
FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanismsTomohiro Mita, Masato Furuhashi, Shinya Hiramitsu, et al.Journal of the American Heart Association|March 29, 2021
Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass GraftingTakuma Mikami, Masato Furuhashi, Akiko Sakai, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|February 5, 2023
Comparison of Phenotypes in Subcutaneous Fat and Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass GraftingTakuma Mikami, Masato Furuhashi, Ryosuke Numaguchi, et al.Journal of Diabetes Investigation|December 26, 2024
Urinary fatty acid-binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitusMarenao Tanaka, Tatsuya Sato, Tomohito Gohda, et al.Clinical Kidney Journal|April 10, 2025
Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort studyMarenao Tanaka, Tatsuya Sato, Tomohito Gohda, et al.ESC Heart Failure|July 19, 2022
Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathyYugo Fujita, Toshiyuki Yano, Hiromitsu Kanamori, et al.Clinical and Experimental Nephrology|August 21, 2024
Straightforward and immediate ultrasound-guided kidney biopsy using a guide needle technique to get adequate tissue with reduced procedural timeHiroaki Komatsu, Tomohisa Yamashita, Arata Osanami, et al.Cardiovascular Diabetology|August 22, 2014
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general populationTakahiro Fuseya, Masato Furuhashi, Satoshi Yuda, et al.American Journal of Hypertension|May 21, 2014
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blockerMasato Furuhashi, Norihito Moniwa, Tomohiro Mita, et al.Circulation Reports|April 11, 2025
Construction of Predictive Models for Cardiovascular Mortality by Machine Learning Approaches in Patients Who Underwent Transcatheter Aortic Valve ImplantationShunsaku Otomo, Itaru Hosaka, Marenao Tanaka, et al.Pageof 11